Novo Nordisk shares dip as Wegovy maker posts earnings miss, cuts operating profit outlook

Novo Nordisk on Wednesday said its net profit came in at 20.05 billion Danish kroner in the second quarter of 2024, below forecasts.

EBIT — earnings before interest and tax — came in at 25.93 billion Danish kroner in the second quarter, which was also below the LSEG forecast of 26.86 billion Danish kroner.saying growth was now anticipated to come in between 20% and 28%, rather than the previously expected 22% to 30% range. Sales of popular weight loss drug Wegovy jumped 55% in the second quarter of 2024, compared to the same period in 2023, coming in at 11.66 billion kroner.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: NBCLA - 🏆 319. / 59 Read more »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: CNBC - 🏆 12. / 72 Read more »

Shares of Wegovy maker Novo Nordisk slide 5% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: NBCNewYork - 🏆 270. / 63 Read more »

Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: CNBC - 🏆 12. / 72 Read more »